论文信息 - G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab - 字舞流文

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

O. Topolcan | B. Melichar | Z. Bortlíček | T. Buchler | O. Fiala | V. Liska | L. Holubec | B. Mohelníková-Duchoňová | J. Finek | M. Šedivcová | M. Bartoušková | V. M. Matějka | J. Kulhánková